this page only  
Join BIO   |   Member Directory   |    Contact BIO    
Biotechnology Industry Organization
Bio Photo

Home
About BIO
Conferences & Events
Past BIO Events
Industry Calendar
State/Int'l Calendar
Members.BIO.org
BIO News Online
BIO Bulletins
Suggestion Box
Membership Directory
BIO Videos
News & Media
BIO Blogs & Podcasts
National Issues
Health
• Food & Agriculture
Industrial & Environmental
Bioethics
Intellectual Property
Regulatory
Tax & Financial
State & Local Issues
State by State Initiatives
Letters, Testimony & Comments
Speeches & Publications
Industry At-a-Glance
Business & Finance


Monday, December 01, 2008

Labeling Of Biotechnology Food Products

Click here for a printer-friendly page Printer Friendly

Issue in Brief:
Mandatory Labeling of Food Products Based on the Method of Production Is Not Justified


[T]here is no scientific justification for special labeling of genetically modified foods, as a class, and that voluntary labeling is without value unless it is accompanied by focused consumer education.
American Medical Association Council on Scientific Affairs,
Genetically Modified Crops and Foods (I-00) Full Text (2000)


The biotechnology industry supports accurate and informative product labeling that communicates to consumers material information relevant to health, safety and nutrition. Misleading label information makes informed consumer choices harder. BIO believes that a system of mandatory labeling of biotech products would confuse consumers by inaccurately suggesting that these products are inherently different or pose safety concerns when compared with traditional foods.

The food products of biotechnology are subject to the same Food and Drug Administration labeling requirements applied to other foods. The FDA's 1992 policy states that there is no reason to conclude that bioengineered foods differ from other foods in any meaningful or uniform way or that they present a greater safety concern than foods developed using traditional methods. Its position is that foods should be labeled according to their characteristics, not their method of production. Therefore, FDA does not require special labeling of biotechnology foods or the products of animals fed these foods.

FDA policy does require a label on food products, including those produced using biotechnology, when they pose a potential health or safety risk or when there has been a material change in the food and it no longer substantially equivalent to its traditional counterpart. These can include changes in composition, nutritional value or safety. (For more on the concept of substantial equivalence, click here.)

This policy has been supported by a number of scientific groups, including the American Medical Association, American Council on Science and Health, Council for Agricultural Science and Technology and Institute of Food Technologists. A report by AMA, for example, found that "[T]here is no scientific justification for special labeling of genetically modified foods, as a class, and that voluntary labeling is without value unless it is accompanied by focused consumer education."

Mandatory labeling would cost consumers more because bioengineered and traditionally bred foods would have to be segregated, or "identity preserved," throughout the entire distribution system. While economical for high-value products like fresh fruits, fresh vegetables and some grains, the cost to segregate commodity products such as corn and soybeans, which are ingredients in 70 percent of processed foods, would exceed the added value of the enhanced trait. Consumers would therefore be forced to pay higher prices simply to cover the cost of getting foods labeled "biotechnology."

FDA allows manufacturers to make voluntary claims about whether their products contain biotech ingredients. Like all product claims, these must be truthful, clear and not misleading. The FDA has developed labeling guidance for food manufacturers who want to place voluntary claims on labels for food with or without biotech ingredients. This guidance is to ensure that labels provide accurate information.

A voluntary system will allow niche markets to develop that will cater to consumers interested in purchasing products produced in a particular way, as in the case of organic foods. Ultimately, consumers will dictate the degree to which food producers segregate and label biotech products.

The current science-based labeling policy informs and protects consumers by giving them material information about the food product. The idea that food crops improved through biotechnology are not necessarily different from their traditional counterparts, the basis of FDA's regulatory policy, has been supported by the National Academies and other prestigious scientific bodies.

The FDA's policy does not just make sense to scientists; it makes sense to consumers, too. A 2002 survey conducted by the International Food Information Council finds that, once it is explained, nearly six in 10-59 percent-agree with the current FDA labeling policy.

This IFIC survey was consistent with the results of a 2002 Oregon ballot initiative that would have mandated special labeling of biotech foods. Despite a huge effort by biotech opponents, the labeling initiative was rejected by voters 72 to 28 percent. The outcome of the Oregon vote confirms that when consumers are presented with the facts about biotechnology and food labeling issues, they agree with the FDA's existing labeling criteria. Consumers also are aware that the new "organic" certification provides choices for consumers who wish to avoid biotech products.

 

Resources:
Food and Drug Administration:

Other Resources:

For more links, click here.

© 2008 | Biotechnology Industry Organization | 1201 Maryland Ave., SW, Ste. 900 | Washington, D.C. 20024